True about endometrial carcinoma:
## Core Concept
Endometrial carcinoma, also known as endometrial cancer, is a type of cancer that originates in the uterus, specifically in the endometrium, which is the lining of the uterus. It is one of the most common gynecologic malignancies. The core concept here involves understanding the risk factors, types, and characteristics of endometrial carcinoma.
## Why the Correct Answer is Right
The correct answer, , is related to the specifics of endometrial carcinoma, which could involve its histological types, risk factors, or clinical features. Endometrial carcinoma is predominantly of the endometrioid type (adenocarcinoma), which accounts for about 80-90% of cases. It is often associated with unopposed estrogen exposure, which can lead to endometrial hyperplasia and increase the risk of cancer. The correct answer likely highlights a key aspect such as this.
## Why Each Wrong Option is Incorrect
- **Option A:** Without the specific details of option A, we can't directly address why it's incorrect, but generally, options that are incorrect might not align with established risk factors (e.g., lack of estrogen exposure), might not be a common type of endometrial cancer, or could be related to a different condition altogether.
- **Option B:** Similarly, option B would be incorrect based on its inaccuracy regarding endometrial carcinoma, which could involve incorrect associations with risk factors, symptoms, or histological types.
- **Option C:** This option is not provided, but if it were incorrect, it would likely not accurately reflect a characteristic feature or common understanding about endometrial carcinoma.
## Clinical Pearl / High-Yield Fact
A key clinical pearl for endometrial carcinoma is that it is often associated with **postmenopausal bleeding**. This symptom should always prompt an investigation to rule out malignancy. Another important point is that **unopposed estrogen** is a significant risk factor, which is why conditions like estrogen-producing tumors or hormone replacement therapy without progesterone (in women with a uterus) can increase the risk.
## Correct Answer: D.